Eupraxia Pharmaceuticals (EPRX) Earnings Date & Reports

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

EPRX is expected to report earnings to fall 4.85% to -18 cents per share on August 08

Eupraxia Pharmaceuticals EPRX Stock Earnings Reports

Q2'25

Est.

$-0.18

Q1'25

Missed

by $0.02

Q4'24

Missed

by $0.09

Q3'24

Beat

by $0.01

The last earnings report on May 06 showed earnings per share of -18 cents, missing the estimate of -17 cents. With 3.70K shares outstanding, the current market capitalization sits at 135.69M.

View a ticker or compare two or three

Compare

EPRX